Congress Officers
Find out more about the Congress Officers of the ESMO TAT 2025
Three Prominent ESMO Officers Shine in News Pages for Their Accomplishments in Cancer Research
Tom Powles, Editor in Chief of ESMO’s flagship journal Annals of Oncology; Solange Peters, ESMO Past President; and Fabrice André, President Elect of the Society have been recognised as leading and influential researchers for their remarkable achievements in cancer care
Certificate of Attendance
The Evaluation Questionnaire along the certificate of attendance will be available from Friday, 17 May at 10:00 CEST
Feasibility and Safety of Preoperative Treatment with Nivolumab and Relatlimab in Patients with Resectable NSCLC Stages IB, II and IIIA
Findings from the NEOpredict-Lung study
Prolonged use of adjuvant imatinib shows promise in localised GIST
A study reports a disease-free survival benefit with six years of maintenance therapy with imatinib compared to the 3-year standard of care
Fuzuloparib prolongs progression-free survival in HER2 negative metastatic breast cancer
A benefit was observed in women with germline BRCA1/2 mutations when treated with the PARP inhibitor alone or in combination with apatinib